Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Therapeutic Drug Monitoring
|
January 1, 1989
Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity
M W Garrison, J C Rotschafer
The Diabetes Educator
|
November 1, 1993
Identifying and treating common and uncommon infections in the patient with diabetes
M W Garrison, R K Campbell
DICP : the Annals of Pharmacotherapy
|
June 1, 1991
Therapeutic advances in the prevention of hepatitis B: yeast-derived recombinant hepatitis B vaccines
M W Garrison, D E Baker
Journal of Emergency Nursing
|
July 1, 1990
Cincinnati's collaborative response for mass casualty incidents
M W Garrison, G Miller, E Rohan
Clinical Therapeutics
|
January 23, 1999
Levofloxacin: a therapeutic review
S M Wimer, L Schoonover, M W Garrison
Southern Medical Journal
|
November 1, 1989
Suboptimal effect of daptomycin in the treatment of bacteremias
M W Garrison, J C Rotschafer, K B Crossley
Antimicrobial Agents and Chemotherapy
|
June 1, 1996
Activity of once-daily cefpodoxime regimens against Haemophilus influenzae and Streptococcus pneumoniae with an in vitro pharmacodynamic chamber model
M W Garrison, C L Malone, J E Eiland
Pharmacotherapy
|
January 1, 1988
Therapeutic update on glycopeptide and lipopeptide antibiotics
J C Rotschafer, M W Garrison, K A Rodvold
The Annals of Pharmacotherapy
|
December 10, 1997
Agranulocytosis induced by vancomycin or ticarcillin/clavulanate
D L Mandl, M W Garrison, S D Palpant
DICP : the Annals of Pharmacotherapy
|
March 1, 1990
Aminoglycosides: another perspective
M W Garrison, D E Zaske, J C Rotschafer
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Therapeutic Drug Monitoring
|
January 1, 1989
Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity
M W Garrison, J C Rotschafer
The Diabetes Educator
|
November 1, 1993
Identifying and treating common and uncommon infections in the patient with diabetes
M W Garrison, R K Campbell
DICP : the Annals of Pharmacotherapy
|
June 1, 1991
Therapeutic advances in the prevention of hepatitis B: yeast-derived recombinant hepatitis B vaccines
M W Garrison, D E Baker
Journal of Emergency Nursing
|
July 1, 1990
Cincinnati's collaborative response for mass casualty incidents
M W Garrison, G Miller, E Rohan
Clinical Therapeutics
|
January 23, 1999
Levofloxacin: a therapeutic review
S M Wimer, L Schoonover, M W Garrison
Southern Medical Journal
|
November 1, 1989
Suboptimal effect of daptomycin in the treatment of bacteremias
M W Garrison, J C Rotschafer, K B Crossley
Antimicrobial Agents and Chemotherapy
|
June 1, 1996
Activity of once-daily cefpodoxime regimens against Haemophilus influenzae and Streptococcus pneumoniae with an in vitro pharmacodynamic chamber model
M W Garrison, C L Malone, J E Eiland
Pharmacotherapy
|
January 1, 1988
Therapeutic update on glycopeptide and lipopeptide antibiotics
J C Rotschafer, M W Garrison, K A Rodvold
The Annals of Pharmacotherapy
|
December 10, 1997
Agranulocytosis induced by vancomycin or ticarcillin/clavulanate
D L Mandl, M W Garrison, S D Palpant
DICP : the Annals of Pharmacotherapy
|
March 1, 1990
Aminoglycosides: another perspective
M W Garrison, D E Zaske, J C Rotschafer
Page
of 3